Axogen, Inc. — Director's Dealing 2014

Jan 6, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2014-01-02

Reporting Person: Freitag Gregory Gene (Director, CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-02	Common Stock	A	6250	$0.00	Acquired	38901	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-02	Employee Stock Option (right to buy)	$4.81	A	15000	Acquired	2021-01-02	Common Stock (15000)	Direct

Footnotes

F1: Granted by the Board of Directors as 2013 merit compensation.

F2: The grant shares are valued at $4.81 per share, the closing price of Company Common Stock on 1/02/2014, the date of grant.

F3: All shares pursuant to the employee stock option will be fully vested on January 2, 2018 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on January 2, 2015 (12 months from the option grant date) and an additional 12.5% of the aggregate shares each 6 months thereafter.